Ingenus was born in 2010, came to market in 2012 and we are continuously expanding our roster of high impact generic pharmaceutical products. We’ve built Ingenus on a foundation of innovation and collaboration to meet the unique needs of U.S. consumers. Our expansive generic product focus proves it.
With our team of over 140 developers and scientists, Ingenus today is poised to file 15- 25 ANDAs per year.
|
Name
|
Strength
|
NDC/SKU Numbers
|
Case Pack
|
TE Rating
|
Image
|
|---|---|---|---|---|---|
|
Carboplatin Injection
|
450 mg, 45 mL Injection
|
50742-0447-45
|
72
|
AP
|
|
|
//
|
600 mg, 60 mL Injection
|
50742-0448-60
|
56
|
AP
|
|
|
Clofarabine Injection
|
20 mg, 20 mL Injection
|
50742-0512-20
|
126
|
AP
|
|
|
Cyclophosphamide Injection
|
500 mg/2.5 mL (200 mg/mL)
|
50742-0519-02
|
126
|
None
|
|
|
//
|
1 g/5 mL (200 mg/mL)
|
50742-0520-05
|
126
|
None
|
|
|
Decitabine for Injection
|
50 mg/vial
|
50742-0430-01
|
96
|
AP
|
|
|
Docetaxel Injection, USP
|
20 mg, 2 mL Injection
|
50742-0428-02
|
72
|
AP
|
|
|
//
|
80 mg, 8 mL Injection
|
50742-0431-08
|
72
|
AP
|
|
|
//
|
160 mg, 16 mL Injection
|
50742-0463-16
|
72
|
AP
|
|
|
Irinotecan Injection, USP
|
40 mg, 2 mL Injection, USP
|
50742-0401-02
|
216
|
AP
|
|
|
//
|
100 mg, 5 mL Injection, USP
|
50742-0402-05
|
216
|
AP
|
|
|
Levoleucovorin Injection
|
175 mg, 17.5 mL Injection
|
50742-0494-17
|
96
|
AP
|
|
|
//
|
250 mg, 25 mL Injection
|
50742-0495-25
|
96
|
AP
|
|
|
Oxaliplatin Injection, USP
|
50 mg, 10 mL Injection
|
50742-0405-10
|
96
|
AP
|
|
|
//
|
100 mg, 20 mL Injection
|
50742-0406-20
|
96
|
AP
|
|
|
Palonosetron HCl Injection
|
0.25 mg, 5 mL Injection
|
50742-0485-05
|
12
|
AP
|
|
|
Zoledronic Acid Injection
|
4 mg, 5 mL Injection
|
50742-0416-05
|
96
|
AP
|
|